We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eugia Pharma Sees Three 483s Since January, Following Inspections of Plants in India
Eugia Pharma Sees Three 483s Since January, Following Inspections of Plants in India
Three Eugia Pharma plants in India have received Form 483s following inspections conducted in the last two months, all laden with examples of the company failing to follow procedures to prevent microbiological contamination of its drug products, among other lapses.